Infleqtion director granted 33,928 stock options

Infleqtion, Inc. reported that director David B. Singer was granted stock options covering 33,928 shares of common stock at an exercise price of $12.59 per share.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

4/A

Rhea-AI Filing Summary

Infleqtion, Inc. reported that director David B. Singer was granted stock options covering 33,928 shares of common stock at an exercise price of $12.59 per share. The options vest in full on the earlier of May 23, 2027 or the issuer's next annual stockholder meeting after April 10, 2026, subject to his continuous service. These options expire on April 10, 2036. According to the disclosure, the economic benefit of this director compensation passes to Maverick Ventures Investment Fund, L.P. through a management fee offset, and Singer disclaims beneficial ownership except to the extent of his pecuniary interest.

Insider Trade Summary

Grant/Award: 33,928 shares

Grant/Award 1 txn

Insider SINGER DAVID B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	33,928	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 33,928 contracts (Direct)

Footnotes (2)

F1. The options vest in full on the earlier of (i) May 23, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders following April 10, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2026 Equity Incentive Plan) with the Issuer through such date. Vesting shall be subject to any acceleration provisions contained in the Issuer's Non-Employee Director Compensation Policy.
F2. The economic benefit of the director compensation provided in respect of the Reporting Person's board service passes to Maverick Ventures Investment Fund, L.P. through a management fee offset. The Reporting Person disclaims, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

Key Figures

Option grant size: 33,928 options Exercise price: $12.59 per share Post-grant derivative holdings: 33,928 options +1 more

4 metrics

Option grant size 33,928 options Stock options covering 33,928 shares granted to director

Exercise price $12.59 per share Fixed exercise price for the stock option grant

Post-grant derivative holdings 33,928 options Total stock options held following this grant

Expiration date April 10, 2036 Options expire on April 10, 2036 if unexercised

Key Terms

Stock Option (Right to Buy), Continuous Service, 2026 Equity Incentive Plan, Non-Employee Director Compensation Policy, +2 more

6 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

Continuous Service financial

"subject to the Reporting Person's Continuous Service with the Issuer"

2026 Equity Incentive Plan financial

"as defined in the Issuer's 2026 Equity Incentive Plan"

Non-Employee Director Compensation Policy financial

"subject to any acceleration provisions contained in the Issuer's Non-Employee Director Compensation Policy"

management fee offset financial

"passes to Maverick Ventures Investment Fund, L.P. through a management fee offset"

pecuniary interest financial

"disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Infleqtion (CCCX) disclose about David B. Singer's compensation?

Infleqtion disclosed a grant of stock options to director David B. Singer covering 33,928 shares of common stock at a $12.59 exercise price. The award reflects compensation for his board service and is documented in an amended insider ownership report.

How many Infleqtion (CCCX) shares are covered by the new stock options?

The option grant covers 33,928 shares of Infleqtion common stock. Each option gives the right to buy one share at a fixed exercise price, aligning the director’s compensation with future stock performance if the options become valuable.

When do David B. Singer’s Infleqtion (CCCX) options vest?

The options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting after April 10, 2026. Vesting is conditioned on his continuous service and subject to any acceleration under the company’s director compensation policy.

What is the exercise price and expiration date of the Infleqtion (CCCX) options?

The options have a $12.59 per share exercise price and expire on April 10, 2036. This means they can be exercised at that fixed price any time after vesting and before expiration, subject to the applicable plan and agreement terms.

Who ultimately benefits economically from this Infleqtion (CCCX) option grant?

The filing states that the economic benefit of the director compensation passes to Maverick Ventures Investment Fund, L.P. through a management fee offset. David B. Singer disclaims beneficial ownership of the securities except to the extent of his pecuniary interest in them.

Is this Infleqtion (CCCX) transaction a market purchase or sale of shares?

No, this is a grant of stock options as compensation, not a market trade. It represents an award giving the right to buy shares in the future at $12.59, subject to vesting and expiration conditions, rather than an immediate buy or sell in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/15/2026 - 04:15 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SINGER DAVID B

(Last)

(First)

(Middle)

C/O INFLEQTION, INC.

1315 WEST CENTURY DRIVE, SUITE 150

(Street)

LOUISVILLE

COLORADO

80027

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Infleqtion, Inc. [ INFQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
04/14/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$12.59	04/10/2026		A		33,928		⁽¹⁾	04/10/2036	Common Stock	33,928	$0	33,928	D⁽²⁾

Explanation of Responses:

1. The options vest in full on the earlier of (i) May 23, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders following April 10, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2026 Equity Incentive Plan) with the Issuer through such date. Vesting shall be subject to any acceleration provisions contained in the Issuer's Non-Employee Director Compensation Policy.

2. The economic benefit of the director compensation provided in respect of the Reporting Person's board service passes to Maverick Ventures Investment Fund, L.P. through a management fee offset. The Reporting Person disclaims, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

	/s/ Jason D. Hall, Attorney-in-Fact	04/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR